Personalized Neoantigen Vaccine Turns a Patient’s Immune System Into a TCR Discovery Engine
A personalized dendritic cell neoantigen vaccine given to an ovarian cancer patient enabled Swiss researchers to track expanding T-cell clonotypes ...
A personalized dendritic cell neoantigen vaccine given to an ovarian cancer patient enabled Swiss researchers to track expanding T-cell clonotypes ...
A new systematic review reveals how artificial intelligence, generative models, and quantum computing are converging to transform drug discovery and ...
A new Nature Protocols workflow shows that keratinocytes from remotely mailed hair follicles can be reprogrammed into induced pluripotent stem ...
Patient-derived ovarian cancer organoids show that brief chemotherapy exposure reshapes sensitivity to second-line drugs such as cediranib and topotecan without ...
A landmark review traces how organoids, assembloids and endometrium-on-a-chip platforms are transforming the study of human reproduction and women's health.
CAMBRIDGE, United Kingdom — A new commentary published in Frontiers in Medicine argues that the next transformation in healthcare will ...
Around three million people worldwide live with chronic pancreatitis, a debilitating condition marked by persistent inflammation, scarring, and severe pain. ...
In an era where personalized medicine stands at the forefront of biomedical innovation, the intricate relationship between our genetic architecture ...
In the ever-evolving landscape of personalized medicine, a groundbreaking tool known as the "Health Octo" has emerged, bridging the critical ...
Ovarian cancer continues to pose significant challenges in gynecological oncology, particularly regarding its treatment and management strategies. The introduction of ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine